Vinay Prasad’s exit — his second from the agency in less than a year — comes after sharp criticism of his handling of drug ...
Hosted on MSN
Trump threatens Big Pharma heads who don’t lower drug prices with ‘every tool in our arsenal’
President Donald Trump on Thursday demanded that the chief executives of 17 pharmaceutical companies lower their drug prices for U.S. consumers or else face "every tool in our arsenal." Trump issued ...
President Donald Trump signed a memo on Sept. 9 to increase enforcement actions against companies that use direct-to-consumer pharmaceutical advertisements and do not adequately disclose side effects ...
The pharmaceutical industry is engaging in a flurry of biotech deals and shifting clinical trials to China. It does so at a time when the U.S. is distancing from China.
Amid growing regulatory pressures, including IRA pricing reforms, RevSavvy reports increasing adoption of its ARC platform and consulting services to help pharmaceutical companies manage system ...
Pharmaceutical companies are navigating a changing landscape defined by GLP-1 innovation, AI-supported drug discovery, and evolving healthcare consumption patterns. Why Are Investors Re-Evaluating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results